Nanoexa Supply Clean Room Technology to Lithium Ion Battery Manufacturer Decktron

Nanoexa, a nanotechnology-based clean energy company, today announced that the company has delivered new technology to Decktron, Nanoexa's publicly traded subsidiary in Korea, as a result of a Non-Recurring Engineering (NRE) agreement. Decktron, an advanced technology manufacturing company, will apply the nanotechnology to the development of a new generation of lithium ion batteries.

"This new nanotechnology will enable Decktron to create the best batteries on the market," said S. S. Kim, Chief Strategy Officer of Decktron. "Since we partnered with Nanoexa last fall, we have been confident in the company's continued ability to provide Decktron with the kind of technology that will secure our position as the battery industry leader."

To be used in combination with existing intellectual property from Argonne National Laboratory, the technology is based on a positive electrode material that is comprised of a unique nano-crystalline layered-layered composite structure. This cathode technology will give Decktron's batteries the ability to deliver more than 3000 W/kg, making Decktron's lithium batteries among the best-performing on the market today. In addition to the technology, the intellectual property transfer includes a description of low-cost, scaleable methods to manufacture positive electrode material in high volume.

"This rapid IP output and subsequent technology transfer affirms Nanoexa's commitment to commercializing the next wave of battery advancements," said Michael Pak, CEO of Nanoexa. "The layered-layered design of the battery will ensure its stability and safety. We are confident that this agreement with Decktron will result in a safe energy storage solution perfect for the power tool and HEV markets."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.